Phoebe Gates Startup Draws Tracking Scrutiny
THE SO WHAT
Overwriting affiliate tracking cookies to redirect commissions is exactly the kind of growth hack that now gets litigated in public. Any commerce or adtech product that touches attribution needs a clear, auditable story on whose incentives it’s rewriting—and consent flows to match.
READ THE SOURCE
MORE FROM THE WIRE
I'm a writer who left LA for an AI startup in San Francisco. It was like stepping into a whole new world.
Non-technical talent jumping coasts for early-stage AI startups is a reminder that narrative, ops, and GTM are now as scarce as model talent. Founders should treat strong generalists from adjacent creative fields as core hires, not nice-to-have marketing add-ons.
Startups & VentureReed Jobs would rather talk about curing cancer than his last name
A 17-person Yosemite team leaning into oncology as blockbuster patents expire means more capital chasing post-patent white space—companion diagnostics, delivery tech, and next-gen therapies. If you operate in healthcare or biotech tooling, expect sharper diligence around real clinical leverage, not just AI-on-biology narratives.
Startups & VentureGensler: Big Deals a Sign of 'High-Valuation Market'
When SK Hynix can raise $26.5B and Google can float an $85B deal, you’re operating in a high‑valuation regime where public markets are rewarding scale and story. For late‑stage companies, that’s a window to consider listing or secondary liquidity—while also tightening fundamentals in case multiples compress.
Startups & VentureHedge Fund Elliott Builds Stake in Software Firm CCC
Activist capital building a stake in a vertical software player exploring a sale is a reminder that underpriced, cash‑generating SaaS is now an M&A and activism target. If you run a similar asset, assume your valuation and strategic options are being modeled by funds—have a defensible plan or a sale narrative ready.